Key statistics
On Monday, Ginkgo Bioworks Holdings Inc (DNA:NYQ) closed at 7.05, 41.00% above the 52 week low of 5.00 set on Apr 04, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 6.52 |
|---|---|
| High | 7.17 |
| Low | 6.35 |
| Bid | 6.94 |
| Offer | 7.05 |
| Previous close | 6.75 |
| Average volume | 1.19m |
|---|---|
| Shares outstanding | 58.92m |
| Free float | 45.17m |
| P/E (TTM) | -- |
| Market cap | 397.74m USD |
| EPS (TTM) | -6.22 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 21:00 GMT.
More ▼
- Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure
- Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business
- Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation
- Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural Products
- Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-of-the-Art Scientific Benchmark
- Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
- Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach
- Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil Amendment
- Ginkgo Bioworks partners on Deep Origin-led team to develop new tools for predicting drug safety
- Ginkgo Bioworks Selected by PNNL to Deliver a Modular, High‑Throughput Phenotyping Platform for DOE's M2PC
More ▼
